MAPT and Alzheimer disease: The same research group showed that H. pylori TN2GF4 infection induces significant tau hyperphosphorylation with activation of glycogen synthase kinase-3β (GSK-3β) and that treatment with GSK-3 inhibitors significantly attenuated H. pylori-induced AD pathology (78).